Catalyst Wire Dossier Catalyst Wire Dossier

Lepirudin

lepirudin
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Lepirudin, covering 2008-03-04 to 2016-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing